Literature DB >> 8538665

Single-fiber electromyography in diabetic peripheral polyneuropathy.

V Bril1, M R Werb, D A Greene, A A Sima.   

Abstract

In this study we examined the value of single-fiber electromyography (SFEMG) in assessing the degree of reinnervation in diabetic patients with clinical neuropathy. Relationships between reinnervation and the degree of metabolic control, and/or duration of diabetes were examined. Thirty-six insulin-dependent diabetics and 54 non-insulin-dependent diabetics underwent SFEMG examination of the tibialis anterior muscle, as well as conventional nerve conduction studies of the upper and lower limbs. All patients examined exhibited some abnormality of SFEMG even in the presence of normal nerve conduction studies found in 18% of patients. In diabetic patients, the jitter in the tibialis anterior muscle correlated positively with glycosylated hemoglobin; whereas lower limb nerve conduction studies did not correlate with this measure of diabetic control. These data suggest that SFEMG is a sensitive measure of nerve function and reinnervation and that it may reflect the dynamic changes in metabolic status in diabetic patients.

Entities:  

Mesh:

Year:  1996        PMID: 8538665     DOI: 10.1002/(SICI)1097-4598(199601)19:1<2::AID-MUS1>3.0.CO;2-J

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Subclinical diabetic neuropathy with normal conventional electrophysiological study.

Authors:  Jong Seok Bae; Byoung Joon Kim
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

2.  Comparison of two electrophysiological methods for the assessment of progress in a rat model of nerve repair.

Authors:  Dong Han; Jiuzhou Lu; Lei Xu; Jianguang Xu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Motor unit number and transmission stability in octogenarian world class athletes: Can age-related deficits be outrun?

Authors:  Geoffrey A Power; Matti D Allen; Kevin J Gilmore; Daniel W Stashuk; Timothy J Doherty; Russell T Hepple; Tanja Taivassalo; Charles L Rice
Journal:  J Appl Physiol (1985)       Date:  2016-03-24

4.  Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy.

Authors:  Matti D Allen; Brendan Major; Kurt Kimpinski; Timothy J Doherty; Charles L Rice
Journal:  J Appl Physiol (1985)       Date:  2013-12-19

Review 5.  Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy.

Authors:  Prodromos Parasoglou; Smita Rao; Jill M Slade
Journal:  Clin Ther       Date:  2017-05-30       Impact factor: 3.393

6.  Accelerated atrophy of lower leg and foot muscles--a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI).

Authors:  C S Andreassen; J Jakobsen; S Ringgaard; N Ejskjaer; H Andersen
Journal:  Diabetologia       Date:  2009-03-12       Impact factor: 10.122

7.  Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.

Authors:  Hong Jiang; Yi Xiang; Xingyue Hu; Huaying Cai
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

8.  Maintaining Motor Units into Old Age: Running the Final Common Pathway.

Authors:  Geoffrey A Power; Brian H Dalton; Kevin J Gilmore; Matti D Allen; Timothy J Doherty; Charles L Rice
Journal:  Eur J Transl Myol       Date:  2017-03-24

9.  The Physiological Significance of A-Waves in Early Diabetic Neuropathy: Assessment of Motor Nerve Fibers by Neurophysiological Techniques.

Authors:  Qiong Cai; Guliqiemu Aimair; Wen-Xiao Xu; Pei-Yao Xiao; Lie-Hua Liu; Yin-Xing Liang; Chao Wu; Song-Jie Liao
Journal:  Front Syst Neurosci       Date:  2021-01-28

10.  Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study.

Authors:  Jaime Hernández-Ojeda; Luis Miguel Román-Pintos; Adolfo Daniel Rodríguez-Carrízalez; Rogelio Troyo-Sanromán; Ernesto Germán Cardona-Muñoz; María Del Pilar Alatorre-Carranza; Alejandra Guillermina Miranda-Díaz
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-04       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.